Ac Immune Sa (ACIU)

Dec 15, 2025

AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD - Seeking Alpha

Dec 15, 2025

Dec 12, 2025

AC Immune SA (ACIU) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 12, 2025

Dec 12, 2025

Performance Recap: Will AC Immune SA stock outperform growth indexesJuly 2025 News Drivers & AI Powered Trade Plan Recommendations - moha.gov.vn

Dec 12, 2025

Dec 12, 2025

Aug Macro: Will AC Immune SA IMR stock outperform value peers2025 Technical Overview & Precise Swing Trade Alerts - moha.gov.vn

Dec 12, 2025

Dec 12, 2025

AC Immune Perks Up On Positive Parkinson’s Data - Citeline News & Insights

Dec 12, 2025

Dec 12, 2025

AC Immune reports promising phase 2 results for Parkinson’s therapy - MSN

Dec 12, 2025

Dec 11, 2025

AC Immune’s Parkinson’s vaccine advances on promising biomarker profile - BioCentury

Dec 11, 2025

Dec 11, 2025

AC Immune Simulates Curiosity in Neurodegenerative Fight with Global Conference Plans - StocksToTrade

Dec 11, 2025

Dec 11, 2025

AC Immune (ACIU) Stock: Surges as ACI-7104.056 Shows Potential in Early Parkinson’s Disease - parameter.io

Dec 11, 2025

Dec 11, 2025

AC Immune Trial Shows Early Signs Immunotherapy May Slow Parkinson's - Benzinga

Dec 11, 2025

Dec 11, 2025

Promising Advancements in Parkinson’s Treatment: AC Immune’s ACI-7104 Vaccine Shows Groundbreaking Results - TipRanks

Dec 11, 2025

Dec 11, 2025

Why Is AC Immune Stock Up Over 23% Today? - Asianet Newsable

Dec 11, 2025

Dec 11, 2025

AC Immune SA: Navigating Market Momentum - timothysykes.com

Dec 11, 2025

Dec 11, 2025

ACIU Surges 30% on Positive Parkinson's Therapy Trial Results - GuruFocus

Dec 11, 2025

Dec 11, 2025

AC Immune’s Parkinson’s disease candidate shows positive Phase 2 results - TipRanks

Dec 11, 2025

Dec 11, 2025

ACIU: ACI-7104.056 shows promise in slowing Parkinson's progression with strong safety and efficacy - TradingView

Dec 11, 2025

Dec 11, 2025

AC Immune’s Parkinson’s treatment shows promise in slowing disease - Investing.com

Dec 11, 2025

Dec 11, 2025

AC Immune surges on Parkinson’s drug data (ACIU:NASDAQ) - Seeking Alpha

Dec 11, 2025

Dec 11, 2025

AC Immune (ACIU) Reports Encouraging Phase 2 Results for Parkins - GuruFocus

Dec 11, 2025

Dec 11, 2025

Ac Immune shares climb 32.6% premarket after co reports positive trial data for Parkinson's disease therapy - marketscreener.com

Dec 11, 2025

Dec 11, 2025

AC Immune stock rises after positive Parkinson’s disease trial data - Investing.com India

Dec 11, 2025

Dec 11, 2025

AC Immune Reports Promising Phase 2 Results for Parkinson’s Therapy - TipRanks

Dec 11, 2025

Dec 11, 2025

AC Immune Reports Positive Interim Phase 2 Data for ACI-7104.056 Indicating Potential to Slow Parkinson's Disease Progression - Quiver Quantitative

Dec 11, 2025

Dec 11, 2025

AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease - GlobeNewswire Inc.

Dec 11, 2025

Dec 10, 2025

AC Immune SA's (NASDAQ:ACIU) stock price dropped 11% last week; retail investors would not be happy - simplywall.st

Dec 10, 2025

Dec 09, 2025

Sentiment Watch: Will AC Immune SA stock deliver long term returns - moha.gov.vn

Dec 09, 2025

Dec 06, 2025

Aug Reactions: Why ETFs are accumulating AC Immune SA IMR stockEarnings Risk Summary & Daily Stock Trend Watchlist - BỘ NỘI VỤ

Dec 06, 2025

Dec 05, 2025

Quarterly Risk: Why analysts upgrade AC Immune SA stock2025 Sector Review & Fast Momentum Stock Entry Tips - BỘ NỘI VỤ

Dec 05, 2025

Dec 05, 2025

How AC Immune SA (IMR) stock reacts to weak economyVolume Spike & Weekly High Potential Alerts - Newser

Dec 05, 2025

Dec 05, 2025

Is AC Immune SA (IMR) stock a top dividend aristocrat candidate2025 Short Interest & Reliable Price Action Trade Plans - Newser

Dec 05, 2025

Dec 04, 2025

How big funds are accumulating AC Immune SA (IMR) stock2025 Market Sentiment & Free Reliable Trade Execution Plans - Newser

Dec 04, 2025

Dec 04, 2025

Will AC Immune SA (IMR) stock profit from AI boomCPI Data & Comprehensive Market Scan Insights - Newser

Dec 04, 2025

Dec 04, 2025

Why AC Immune SA (IMR) stock trades below fair valueQuarterly Market Review & Capital Efficiency Focused Strategies - Newser

Dec 04, 2025

Dec 04, 2025

How geopolitical risks impact AC Immune SA (IMR) stock2025 Volume Leaders & Fast Entry Momentum Alerts - Newser

Dec 04, 2025

Dec 02, 2025

Will AC Immune SA (IMR) stock benefit from commodity supercycleWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser

Dec 02, 2025

Nov 30, 2025

What analysts say about AC Immune SA IMR stockShort Selling Opportunities & Free Explosive Wealth Accumulation - earlytimes.in

Nov 30, 2025

Nov 26, 2025

Adversity is less terrifying than hope: AC Immune SA (ACIU) - Setenews

Nov 26, 2025

Nov 21, 2025

Is AC Immune SA stock a top pick in earnings seasonQuarterly Trade Report & Expert Approved Momentum Ideas - newser.com

Nov 21, 2025

Nov 21, 2025

Why millennials buy AC Immune SA (IMR) stockJuly 2025 Catalysts & Fast Exit Strategy with Risk Control - newser.com

Nov 21, 2025

Nov 21, 2025

Will AC Immune SA stock recover faster than peersJuly 2025 Macro Moves & Community Supported Trade Ideas - newser.com

Nov 21, 2025

Nov 21, 2025

Is AC Immune SA (IMR) stock positioned for digital growth eraJuly 2025 Short Interest & AI Powered Buy/Sell Recommendations - newser.com

Nov 21, 2025

Nov 19, 2025

Why analysts remain bullish on AC Immune SA stockGDP Growth & Pattern Based Trade Signal System - newser.com

Nov 19, 2025

Nov 19, 2025

Can AC Immune SA stock resist sector downturnsEarnings Risk Summary & Expert Curated Trade Setup Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Signal strength of AC Immune SA stock in tech scannersBuy Signal & Momentum Based Trading Signals - newser.com

Nov 19, 2025